Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study

An anti-angiogenic cleaved prolactin fragment is considered causal for peripartum cardiomyopathy (PPCM). Experimental and first clinical observations suggested beneficial effects of the prolactin release inhibitor bromocriptine in PPCM. In this multicentre trial, 63 PPCM patients with left ventricul...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European heart journal 2017-09, Vol.38 (35), p.2671-2679
Hauptverfasser:	Hilfiker-Kleiner, Denise, Haghikia, Arash, Berliner, Dominik, Vogel-Claussen, Jens, Schwab, Johannes, Franke, Annegret, Schwarzkopf, Marziel, Ehlermann, Philipp, Pfister, Roman, Michels, Guido, Westenfeld, Ralf, Stangl, Verena, Kindermann, Ingrid, Kühl, Uwe, Angermann, Christiane E, Schlitt, Axel, Fischer, Dieter, Podewski, Edith, Böhm, Michael, Sliwa, Karen, Bauersachs, Johann
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Bromocriptine - administration & dosage Bromocriptine - adverse effects Cardiomyopathies - drug therapy Cardiotonic Agents - administration & dosage Cardiotonic Agents - adverse effects Drug Administration Schedule Editor's Choice Fast Track Fast Track Clinical Research Female Humans Pregnancy Pregnancy Complications, Cardiovascular - drug therapy Puerperal Disorders - drug therapy Recovery of Function - physiology Treatment Outcome Ventricular Dysfunction, Left - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!